Where is ViewRay headquartered?

ViewRay is located in Oakwood Village, OH.

Who invested in ViewRay?

ViewRay has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for ViewRay?

ViewRay closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

viewray.com

ViewRay

ViewRay is an Ohio-based medical device company that develops and commercializes radiation therapy systems for hospitals and laboratories.

Business Model:

Revenue: $87.9M

Employees: 201-500

Geographic Data

Address: 2 Thermo Fisher Way

City: Oakwood Village

State: OH

Zip: 44146

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$81M

Raised Total:

$753M

Social

Facebook

Twitter

Crunchbase

Metrics

1,222,998Website Global Rank

24,620Website Monthly Traffic

Twitter Followers

Description

ViewRay is an Ohio-based medical device company that develops and commercializes radiation therapy systems for hospitals and laboratories.

Contact Phone:
+14407033210

Contact Email:

IPO Details

ViewRay went public on 8/18/2015 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
8/18/2015

Ticker Symbol:
VRAY

Live

Opened: -/share

EBITDA	-
Total Cash	-
Total Debt	-
Total Revenue	-
Total Profit (Gross)	-
PE Ratio	-

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
8/2007	Series A		$3M
5/2013	Venture Round	5	$15M	OrbiMed Next47 Kearny Venture Partners F-Prime Capital Aisling Capital OrbiMed Next47 Kearny Venture Partners F-Prime Capital Aisling Capital
3/2015	Venture Round		$15M
1/2008	Series B	5	$25M	OrbiMed Kearny Venture Partners F-Prime Capital Eight Roads Ventures Aisling Capital OrbiMed Kearny Venture Partners F-Prime Capital Eight Roads Ventures Aisling Capital
12/2013	Venture Round		$0	Kearny Venture Partners OrbiMed Hercules Capital F-Prime Capital Aisling Capital Kearny Venture Partners OrbiMed Hercules Capital F-Prime Capital Aisling Capital
3/2012	Series C	5	$45M	OrbiMed Next47 Kearny Venture Partners F-Prime Capital Aisling Capital OrbiMed Next47 Kearny Venture Partners F-Prime Capital Aisling Capital
8/2015	Post-IPO Equity		$2.7M
1/2019	Debt Financing	1	$56M	Armentum Partners Armentum Partners
10/2017	Post-IPO Equity		$50M
11/2021	Post-IPO Equity		$80.5M
11/2022	Post-IPO Debt		$100M	MidCap Financial Silicon Valley Bank
8/2018	Post-IPO Equity		$172.5M
9/2011	Debt Financing	5	$10M	OrbiMed Next47 Kearny Venture Partners F-Prime Capital Aisling Capital OrbiMed Next47 Kearny Venture Partners F-Prime Capital Aisling Capital
2/2018	Post-IPO Equity		$59M
8/2010	Series C	5	$20M	OrbiMed Next47 Kearny Venture Partners F-Prime Capital Aisling Capital OrbiMed Next47 Kearny Venture Partners F-Prime Capital Aisling Capital
12/2019	Post-IPO Equity	1	$36M	Elekta Elekta Elekta Elekta
11/2021	Post-IPO Equity		$70M
8/2016	Post-IPO Equity		$0	Xeraya Capital OrbiMed Kearny Venture Partners Kearny Venture Partners OrbiMed Xeraya Capital Xeraya Capital OrbiMed Kearny Venture Partners Kearny Venture Partners OrbiMed Xeraya Capital
1/2015	Series C		$16.3M
6/2015	Post-IPO Debt	1	$50M	CRG CRG
11/2022	Post-IPO Debt	2	$125M	Silicon Valley Bank MidCap Financial Silicon Valley Bank MidCap Financial
7/2015	Post-IPO Equity		$0	Aisling Capital Fidelity Kearny Venture Partners Montrose Capital Partners OrbiMed Xeraya Capital Aisling Capital Fidelity Kearny Venture Partners Montrose Capital Partners OrbiMed Xeraya Capital
1/2017	Post-IPO Equity		$0	Acuta Capital Partners Puissance Capital OrbiMed Kearny Venture Partners Puissance Capital Acuta Capital Partners Puissance Capital OrbiMed Kearny Venture Partners Puissance Capital
1/2017	Post-IPO Equity	4	$26.1M	Acuta Capital Partners Puissance Capital OrbiMed Kearny Venture Partners Puissance Capital Acuta Capital Partners Puissance Capital OrbiMed Kearny Venture Partners Puissance Capital
8/2016	Post-IPO Equity	3	$14M	Xeraya Capital OrbiMed Kearny Venture Partners Kearny Venture Partners OrbiMed Xeraya Capital Xeraya Capital OrbiMed Kearny Venture Partners Kearny Venture Partners OrbiMed Xeraya Capital
7/2015	Post-IPO Equity	6	$26.7M	Aisling Capital Aisling Capital

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details